273 related articles for article (PubMed ID: 21872576)
41. Localisation and expression of a myelin associated neurite inhibitor, Nogo-A and its receptor Nogo-receptor by mammalian CNS cells.
Nyatia E; Lang DM
Res Vet Sci; 2007 Dec; 83(3):287-301. PubMed ID: 17428512
[TBL] [Abstract][Full Text] [Related]
42. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
Kim JE; Liu BP; Park JH; Strittmatter SM
Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
[TBL] [Abstract][Full Text] [Related]
43. Selective decline of Nogo mRNA in the aging brain.
Trifunovski A; Josephson A; Bickford PC; Olson L; Brené S
Neuroreport; 2006 Jun; 17(9):913-6. PubMed ID: 16738487
[TBL] [Abstract][Full Text] [Related]
44. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor.
Liu BP; Fournier A; GrandPré T; Strittmatter SM
Science; 2002 Aug; 297(5584):1190-3. PubMed ID: 12089450
[TBL] [Abstract][Full Text] [Related]
45. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration.
McGee AW; Strittmatter SM
Trends Neurosci; 2003 Apr; 26(4):193-8. PubMed ID: 12689770
[TBL] [Abstract][Full Text] [Related]
46. AMIGO3 is an NgR1/p75 co-receptor signalling axon growth inhibition in the acute phase of adult central nervous system injury.
Ahmed Z; Douglas MR; John G; Berry M; Logan A
PLoS One; 2013; 8(4):e61878. PubMed ID: 23613963
[TBL] [Abstract][Full Text] [Related]
47. PirB is a functional receptor for myelin inhibitors of axonal regeneration.
Atwal JK; Pinkston-Gosse J; Syken J; Stawicki S; Wu Y; Shatz C; Tessier-Lavigne M
Science; 2008 Nov; 322(5903):967-70. PubMed ID: 18988857
[TBL] [Abstract][Full Text] [Related]
48. LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury.
Ji B; Li M; Wu WT; Yick LW; Lee X; Shao Z; Wang J; So KF; McCoy JM; Pepinsky RB; Mi S; Relton JK
Mol Cell Neurosci; 2006 Nov; 33(3):311-20. PubMed ID: 17011208
[TBL] [Abstract][Full Text] [Related]
49. Expression of Nogo receptor 1 in microglia during development and following traumatic brain injury.
Liu G; Ni J; Mao L; Yan M; Pang T; Liao H
Brain Res; 2015 Nov; 1627():41-51. PubMed ID: 26367446
[TBL] [Abstract][Full Text] [Related]
50. Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury.
Walmsley AR; Mir AK
Curr Pharm Des; 2007; 13(24):2470-84. PubMed ID: 17692015
[TBL] [Abstract][Full Text] [Related]
51. Nogo-receptors NgR1 and NgR2 do not mediate regulation of CD4 T helper responses and CNS repair in experimental autoimmune encephalomyelitis.
Steinbach K; McDonald CL; Reindl M; Schweigreiter R; Bandtlow C; Martin R
PLoS One; 2011; 6(11):e26341. PubMed ID: 22096481
[TBL] [Abstract][Full Text] [Related]
52. Zinc metalloproteinase-mediated cleavage of the human Nogo-66 receptor.
Walmsley AR; McCombie G; Neumann U; Marcellin D; Hillenbrand R; Mir AK; Frentzel S
J Cell Sci; 2004 Sep; 117(Pt 19):4591-602. PubMed ID: 15331667
[TBL] [Abstract][Full Text] [Related]
53. NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans.
Dickendesher TL; Baldwin KT; Mironova YA; Koriyama Y; Raiker SJ; Askew KL; Wood A; Geoffroy CG; Zheng B; Liepmann CD; Katagiri Y; Benowitz LI; Geller HM; Giger RJ
Nat Neurosci; 2012 Mar; 15(5):703-12. PubMed ID: 22406547
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of Nogo-66 receptor 1 enhances recovery of cognitive function after traumatic brain injury in mice.
Tong J; Liu W; Wang X; Han X; Hyrien O; Samadani U; Smith DH; Huang JH
J Neurotrauma; 2013 Feb; 30(4):247-58. PubMed ID: 22967270
[TBL] [Abstract][Full Text] [Related]
55. Cartilage acidic protein-1B (LOTUS), an endogenous Nogo receptor antagonist for axon tract formation.
Sato Y; Iketani M; Kurihara Y; Yamaguchi M; Yamashita N; Nakamura F; Arie Y; Kawasaki T; Hirata T; Abe T; Kiyonari H; Strittmatter SM; Goshima Y; Takei K
Science; 2011 Aug; 333(6043):769-73. PubMed ID: 21817055
[TBL] [Abstract][Full Text] [Related]
56. Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA.
Schweigreiter R; Walmsley AR; Niederöst B; Zimmermann DR; Oertle T; Casademunt E; Frentzel S; Dechant G; Mir A; Bandtlow CE
Mol Cell Neurosci; 2004 Oct; 27(2):163-74. PubMed ID: 15485772
[TBL] [Abstract][Full Text] [Related]
57. Nogo and Nogo receptor: relevance to schizophrenia?
Willi R; Schwab ME
Neurobiol Dis; 2013 Jun; 54():150-7. PubMed ID: 23369871
[TBL] [Abstract][Full Text] [Related]
58. Troy/Taj and its role in CNS axon regeneration.
Mi S
Cytokine Growth Factor Rev; 2008; 19(3-4):245-51. PubMed ID: 18524667
[TBL] [Abstract][Full Text] [Related]
59. The carboxyl-terminal region of Crtac1B/LOTUS acts as a functional domain in endogenous antagonism to Nogo receptor-1.
Kurihara Y; Arie Y; Iketani M; Ito H; Nishiyama K; Sato Y; Nakamura F; Mizuki N; Goshima Y; Takei K
Biochem Biophys Res Commun; 2012 Feb; 418(2):390-5. PubMed ID: 22281491
[TBL] [Abstract][Full Text] [Related]
60. Developmental analysis of Lingo-1/Lern1 protein expression in the mouse brain: interaction of its intracellular domain with Myt1l.
Llorens F; Gil V; Iraola S; Carim-Todd L; Martí E; Estivill X; Soriano E; del Rio JA; Sumoy L
Dev Neurobiol; 2008 Mar; 68(4):521-41. PubMed ID: 18186492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
